Skip to main content

Table 4 Life-support therapy during hospital stay in the study population of 1,488 patients with septic shock (EPISS study - 2009 to 2011).

From: The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study

Treatment

n (%)

Median (IQR) duration

(days)

Vasopressors

1,488 (100%)

4 (2-6)

Inotropes

412 (27.7%)

3 (2-6)

Invasive mechanical ventilation

1,248 (83.9%)

7 (3-14)

Non-invasive ventilation

355 (24.2%)

2 (1-4)

Continuous renal replacement therapy

484 (32.5%)

4 (2-8)

Intermittent hemodialysis

291 (19.6%)

3 (1-5)

Hydrocortisone

937 (63.0%)

N/A

Protein C

28 (1.9%)

N/A

  1. IQR, interquartile range; N/A, not available.